ArticleJournal of medical case reports2026
Jagged-1 mutation is associated with congenital heart defects: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCongenital heart defects (CHD) refer to a wide range of heart structural abnormalities that exist at birth, ranging from malformations with a good prognosis to more complicated and severe lesions. Congenital heart defects can result from mutations in genes encoding cell signaling transducers such as Jagged-1 (JAG1). Mutations in JAG1 are linked to rare autosomal-dominant disorders, often resulting from haploinsufficiency in the Notch signaling pathway, which affects organ development. Reporting novel mutations and associated phenotypes emphasizes the importance of tailored approaches based on individual phenotypic and genotypic profiles. Next-generation sequencing techniques facilitate the detection of disease-associated mutations, enabling the development of personalized management strategies. CASE PRESENTATION: Here, we present a case of a Saudi Arabian female child who was born extremely preterm. She required intubation and mechanical ventilation immediately after birth. She developed bronchopulmonary dysplasia and pulmonary hypertension. At 8 months old, her echocardiogram revealed a large atrial septal defect and a patent ductus arteriosus. She underwent successful patent ductus arteriosus closure. She exhibited severe failure to thrive and was frequently admitted for respiratory infections. Tragically, she passed away at 11 years of age due to pneumonia and pulmonary hypertensive crises. Exome sequencing of the proband, her parents, and her brother identified a previously undescribed likely pathogenic heterozygous missense variant (c.1127A>G) in the JAG1 gene, inherited from her presumed healthy mother, that is associated with an isolated cardiac phenotype.
conclusionAlthough JAG1 mutations typically manifest as Alagille syndrome, this case underscores their phenotypic variability, specifically presenting as an isolated congenital heart defect. The clinical course demonstrates that pulmonary hypertension is a severe complication of an atrial septal defect (ASD), where persistent left-to-right shunting triggers irreversible vascular remodeling and terminal right heart failure. Ultimately, this report confirms the incomplete penetrance characteristic of JAG1 variants and suggests that extreme prematurity may function as a significant epigenetic or environmental modifier.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.